- Home
- BCHT vs ECOR Comparison
BCHT vs ECOR Comparison
Compare BCHT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCHT | ECOR |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 49.1M |
| IPO Year | 2026 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BCHT | ECOR |
|---|---|---|
| Price | $1.40 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $15.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 183.2K | 51.3K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | $13.42 | $33.60 |
| Revenue Next Year | $61.22 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $1.29 | $4.16 |
| 52 Week High | $2.45 | $8.30 |
Technical Indicators
Market Signals| Indicator | BCHT | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 29.53 | 50.48 |
| Support Level | N/A | $4.55 |
| Resistance Level | $1.74 | $6.61 |
| Average True Range (ATR) | 0.14 | 0.49 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 15.69 | 41.61 |
Price Performance
Historical ComparisonAbout BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.